Perceived efficacy, indications, and information sources for medically indigent patients and their healthcare providers regarding dietary supplements

The Annals of Pharmacotherapy
Patrick G ClayKevin A Clauson

Abstract

Evidence exists that medically indigent and minority patients use dietary supplements at rates as high or higher than that of the general population. Safety concerns regarding the use of dietary supplements are further exacerbated by a suboptimal level of patient disclosure and provider inquiry. To determine dietary supplement use, indications, perceived efficacy, and information sources of patients and providers using a pilot study in a clinic for the medically indigent. Five hundred self-administered patient surveys and 50 healthcare provider surveys were made available to any patient at a free health clinic in Kansas City, MO. Surveys were collected and descriptive analyses were performed. Three hundred eleven patient surveys were returned. Of the 37.3% (116/311) of respondents who had used dietary supplements, 13.8% (n = 16) had 10 comorbid conditions. Ninety-six dietary supplements were used for 8 medical condition categories. The 9 agents most frequently reported used were garlic (n = 32), aloe/green tea (n = 27 each), chamomile/echinacea (n = 24 each), St. John's wort (n = 22), ginseng (n = 18), and cranberry/Ginkgo biloba (n = 17 each). Patients reported a broad range of indications for taking dietary supplements. Patie...Continue Reading

References

Jan 28, 1993·The New England Journal of Medicine·D M EisenbergT L Delbanco
Aug 27, 1998·The Journal of the American Board of Family Practice·B M BermanD Reilly
Nov 20, 1998·JAMA : the Journal of the American Medical Association·D M EisenbergR C Kessler
Aug 24, 1999·Southern Medical Journal·S R Plotkin, R Post
Jan 12, 2000·The Annals of Pharmacotherapy·C M Marrone
Feb 22, 2000·Lancet·S C PiscitelliJ Falloon
Feb 22, 2000·Lancet·F RuschitzkaG Noll
Jun 22, 2000·The Annals of Pharmacotherapy·Z G ChangR E Small
Aug 4, 2001·The Annals of Pharmacotherapy·M C Nahata
Oct 26, 2001·The Annals of Pharmacotherapy·A Y LamM A Mohutsky
Sep 24, 2002·The Annals of Pharmacotherapy·Melody Ryan, Mitzi S Johnson
May 30, 2003·The Annals of Pharmacotherapy·Chantal PharandUNKNOWN Canadian Cardiovascular Pharmacists Network
Jul 5, 2003·The Annals of Pharmacotherapy·Melanie J Cupp
Aug 19, 2003·The Annals of Pharmacotherapy·Thomas G Burnakis
Oct 2, 2003·The Annals of Pharmacotherapy·Diana X BharuchaRichard A Niesenbaum
Nov 25, 2003·The Annals of Pharmacotherapy·Christopher P Alderman, Barbara Kiepfer
Jan 27, 2004·The Annals of Pharmacotherapy·José O RiveraArmando González Stuart
Jan 27, 2004·The Annals of Pharmacotherapy·Patricia KrüthChristoph H Gleiter
Jan 27, 2004·The Annals of Pharmacotherapy·Mitchell S BuckleyWalter E Knapp
Jan 30, 2004·Clinical Pharmacology and Therapeutics·J Christopher GorskiStephen D Hall
Feb 3, 2004·The Annals of Pharmacotherapy·Berthold SchneiderMichael Weiser
Feb 26, 2004·Clinical Cardiology·Tomasz StysWilliam Lawson
Mar 10, 2004·The British Journal of Nutrition·Eva M R KovacsMargriet S Westerterp-Plantenga
Mar 17, 2004·Complementary Therapies in Medicine·S M GiveonE Kahan
Mar 18, 2004·The Annals of Pharmacotherapy·Diane L NykampAnthony L Compton
Mar 27, 2004·Alimentary Pharmacology & Therapeutics·L LangmeadD S Rampton
May 11, 2004·The Journal of Clinical Hypertension·Amanda James WilburnMarion R Wofford
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R RazM Dan
Jun 10, 2004·The Annals of Pharmacotherapy·Antonio BianchiRoberto Raschetti
Jul 28, 2004·Archives of Internal Medicine·Yi-Ching YangChih-Jen Chang
Nov 1, 2004·Current Therapeutic Research, Clinical and Experimental·Patrick G ClayAlan Glaros

❮ Previous
Next ❯

Citations

May 19, 2011·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Y L GaoG S Li
Mar 25, 2010·The Annals of Pharmacotherapy·Naveen BilgiEhab Atallah
Mar 10, 2010·Journal of Psychosocial Nursing and Mental Health Services·V Jude Forbes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.